Ledger.Open graph →
SEC Form D · filed July 30, 2020

Imvax, Inc

Offering
$112.4M
Sold
$112.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David Andrews · STAMFORD, CTExec · DirectorArthur W. Howe · Philadelphia, PAExecPeter W. Corr · Philadelphia, PAExec · DirectorTed W. Koutouzis · Philadelphia, PADirectorWendy W. Dicicco · Philadelphia, PADirectorSteven W. Altschuler · Philadelphia, PADirectorJohn W. Furey · Philadelphia, PAExec · DirectorDavid W. Bunning · Philadelphia, PADirectorThomas W. Pfisterer · Philadelphia, PADirectorIra W. Brind · Philadelphia, PADirectorSteven W. Altschuler · Philadelphia, PADirectorDavid Andrews · Seattle, WAExec · DirectorJohn W. Furey · Philadelphia, PAExec · DirectorArthur W. Howe · Encinitas, CAExecDavid W. Bunning · Philadelphia, PADirectorThomas W. Pfisterer · Philadelphia, PADirectorPeter W. Corr · Philadelphia, PAExec · DirectorTed W. Koutouzis · Philadelphia, PADirectorIra W. Brind · Philadelphia, PADirectorWendy W. Dicicco · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗